MCRB
Seres Therapeutics, Inc. - Common Stock (MCRB)
$09
About Seres Therapeutics, Inc. - Common Stock (MCRB)
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
Details
Daily high
$2.20
Daily low
$2.00
Price at open
--
52 Week High
$29.98
52 Week Low
$1.68
Market cap
20.8M
Dividend yield
-
Volume
2
Avg. volume
76,404
P/E ratio
-.92
Seres Therapeutics, Inc. - Common Stock News
Details
Daily high
$2.20
Daily low
$2.00
Price at open
--
52 Week High
$29.98
52 Week Low
$1.68
Market cap
20.8M
Dividend yield
-
Volume
2
Avg. volume
76,404
P/E ratio
-.92